Auro Laboratories Ltd vs Trident Lifeline Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Auro Laboratories Ltd is ₹ 249.05 as of 05 May 15:30 . The P/E Ratio of Auro Laboratories Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 25.1 on March 2025 . This represents a CAGR of -6.19% over 3 years The Market Cap of Auro Laboratories Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 295.53 crore on March 2025 . This represents a CAGR of 17.33% over 3 years The revenue of Auro Laboratories Ltd for the Dec '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Trident Lifeline Ltd for the Dec '25 is ₹ 30.34 crore as compare to the Mar '25 revenue of ₹ 35.88 crore. This represent the decline of -15.44% The ebitda of Auro Laboratories Ltd for the Dec '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Trident Lifeline Ltd for the Dec '25 is ₹ 9.72 crore as compare to the Mar '25 ebitda of ₹ 10.4 crore. This represent the decline of -6.54% The net profit of Auro Laboratories Ltd changed from ₹ 0.75 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 4.65 crore over 7 quarters. This represents a CAGR of 83.98% The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Auro Laboratories Ltd

Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.

FAQs for the comparison of Auro Laboratories Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Auro Laboratories Ltd or Trident Lifeline Ltd?

Market cap of Auro Laboratories Ltd is 154 Cr while Market cap of Trident Lifeline Ltd is 300 Cr

What are the key factors driving the stock performance of Auro Laboratories Ltd and Trident Lifeline Ltd?

The stock performance of Auro Laboratories Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Auro Laboratories Ltd and Trident Lifeline Ltd?

As of May 5, 2026, the Auro Laboratories Ltd stock price is INR ₹247.7. On the other hand, Trident Lifeline Ltd stock price is INR ₹251.4.

How do dividend payouts of Auro Laboratories Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Auro Laboratories Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.